-

60th ASH Annual Meeting & Exposition

The premier event in malignant and non-malignant hematology. 60th ASH Meeting will be in San Diego, CA

 

Oncopeptides will present updated data from two ongoing trials, one Poster session and one Oral Session.

 

POSTER Presentation: ANCHOR
Saturday, December 1, 2018, at 06:15 pm PST
San Diego Convention Center, Hall GH
Session Name: 653. Myeloma: Therapy, Excluding Transplantation: Poster I

 

ORAL Presentation: HORIZON
Monday, December 3, 2018, at 08:15 am PST
San Diego Convention Center, Room  6F
Session Name: 653: Myeloma: Therapy, Excluding Transplantation: Antibodies and Targeted Therapies

Upcoming events

Silent Period

-

FDA - Oncologic Drugs Advisory Committee (ODAC) Meeting

The US Food and Drug Administration, FDA, has announced a forthcoming public advisory committee meeting of the Oncologic Drugs Advisory Committee (ODAC), on October 28, 2021 concerning Oncopeptides’ product Pepaxto. The information is in line with the FDA safety alert on July 28, where the FDA stated that a public meeting may be hold to discuss the safety findings from the OCEAN study.

Interim Report Q3 2021

08:00 CET

63rd ASH Annual Meeting & Exposition

-

American Society of Hematology (ASH) 63rd annual meeting with both in-person and virtual participation at the Georgia World Congress Center in Atlanta, Georgia. ASH Annual Meeting & Exposition is the largest event in malignant and non-malignant hematology.

Silent Period

-

Year-end report 2021

08:00 CET

Silent Period

-

Silent Period

-